People: TherapeuticsMD Inc (TXMD.OQ)

TXMD.OQ on NASDAQ Stock Exchange Global Select Market

18 Oct 2019
Change (% chg)

$-0.08 (-2.01%)
Prev Close
Day's High
Day's Low
Avg. Vol
52-wk High
52-wk Low

Finizio, Robert 

Mr. Robert G. Finizio is Chief Executive Officer and Director of TherapeuticsMD, Inc. As co-founder of VitaMedMD, LLC, or VitaMed, our wholly owned subsidiary, he has served as Chief Executive Officer and a director of our company since October 2011. As co-founder of VitaMedMD, LLC, or VitaMed, our wholly owned subsidiary, Mr. Finizio served as its Chief Executive Officer and a director from April 2008 to October 2011. Mr. Finizio has 16 years of successful early stage company development experience in the health care industry. Mr. Finizio co-founded and served from August 2001 to February 2008 as President of Care Fusion, LLC and then as Chief Executive Officer of CareFusion, Inc., a clinical technology vendor, which was acquired by Cardinal Health, Inc. Mr. Finizio’s early business experience was with Omnicell, Inc. (formerly known as Omnicell Technologies, Inc.), a provider of pharmaceutical supply chain management systems and services, and Endoscopy Specialists, Inc. in the health care IT and surgical space. We believe Mr. Finizio’s intimate knowledge and experience with all aspects of the business, operations, opportunities, and challenges of our company and experience with early stage company development in the health care industry provide the requisite qualifications, skills, perspectives, and experience that make him well qualified to serve on our Board of Directors. Mr. Finizio earned a B.A. from the University of Miami.

Basic Compensation

Total Annual Compensation, USD 750,000
Restricted Stock Award, USD --
Long-Term Incentive Plans, USD --
All Other, USD 1,974,580
Fiscal Year Total, USD 2,724,580

Options Compensation

  Quantity Market Value
Exercisable -- --
Unexercisable -- --
Exercised 1,472,910 7,496,740.00
Name Fiscal Year Total

Tommy Thompson


John Milligan


Robert Finizio


Brian Bernick


Daniel Cartwright


Michael Donegan

As Of  31 Dec 2018